Stryker Corporation
SYK · Healthcare · Health Care
Updated 27 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #137 of 500 by Iconic Score · #17 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Stryker Corporation (SYK) is a leading global medical technology company specializing in the development and manufacturing of innovative medical devices, surgical equipment, and orthopedic implants. With a market capitalization of $121.0 billion, Stryker is positioned as a key player in the healthcare sector, providing solutions that enhance patient care and improve surgical outcomes. The company's diverse product portfolio includes instruments for minimally invasive procedures, neurotechnology, and spine surgery, catering to hospitals and healthcare providers worldwide. Stryker's commitment to research and development, along with its strategic acquisitions, bolsters its competitive edge and market presence. As healthcare continues to evolve, Stryker’s focus on innovation and quality positions it as a critical contributor to advancements in medical technology, making it an important entity in the global healthcare landscape.
IconicOracleAI™ Brief
Stryker Corp's Iconic Score of 55 reflects a moderate brand presence amid recent market fluctuations, with a market cap of $116.1B and a price decline of 2.23%. The company's brand visibility remains strong at 85/100, bolstered by positive headlines such as the FDA clearance for its Sonopet 3, which enhances surgical accuracy. However, competitive discussions around value stocks, including comparisons with PAHC, may be contributing to mixed sentiment in the market.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.